1990
DOI: 10.1016/0140-6736(90)91158-7
|View full text |Cite
|
Sign up to set email alerts
|

Recovery of failing liver after auxiliary heterotopic transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
24
0

Year Published

1992
1992
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(24 citation statements)
references
References 4 publications
0
24
0
Order By: Relevance
“…In the former, especially in young patients, recovery of liver function and full regeneration of liver cells of the native liver, as well as the eventual withdrawal of immunosuppression, can be expected (6). Auxiliary heterotopic liver transplantation for fulminant hepatitis has antedated APOLT (9,10). In comparison with auxiliary heterotopic liver transplantation, APOLT has some physiologic advantages, such as those relating to portal blood flow, abdominal tissue perfusion, and venous return to the heart.…”
mentioning
confidence: 99%
“…In the former, especially in young patients, recovery of liver function and full regeneration of liver cells of the native liver, as well as the eventual withdrawal of immunosuppression, can be expected (6). Auxiliary heterotopic liver transplantation for fulminant hepatitis has antedated APOLT (9,10). In comparison with auxiliary heterotopic liver transplantation, APOLT has some physiologic advantages, such as those relating to portal blood flow, abdominal tissue perfusion, and venous return to the heart.…”
mentioning
confidence: 99%
“…[10][11][12][13][14][15][16] Although the experience with auxiliary heterotopic liver transplantation was satisfactory, it appears that auxiliary partial orthotopic liver transplantation (APOLT) had some advantages, including improved portal and systemic vein blood flow and abdominal tissue perfusion. 17,18 One also should note that although rather limited, experience with bioartificial liver systems also showed a regenerative potential of not only hepatocytes, but also of nonparenchymal cells, including the stellate cells. 19,20 The recent report published in Modern Pathology describes a 22-year-old patient who underwent APOLT for fulminant liver failure caused by hepatitis B virus infection.…”
Section: Commentsmentioning
confidence: 99%
“…As a result, HALT has been reintroduced as a valid option [16]. However, in cases of HALT for FHF or noncirrhotic metabolic liver disease, there have been several experimental [17,18] and clinical [19][20][21] reports of insufficient portal blood flow to the graft leading to graft atrophy. This may be due in part to the fact that the vascular resistance in the nonfibrotic native liver is often lower than that in the graft.…”
Section: Introductionmentioning
confidence: 99%
“…This may be due in part to the fact that the vascular resistance in the nonfibrotic native liver is often lower than that in the graft. The strategy recommended by the authors of these studies was banding of the portal vein to the native liver [18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%